Text Size
28 studies found for:    " October 10, 2012":" November 09, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" October 10, 2012":" November 09, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df
2 Recruiting Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df;   Drug: ritonavir + atazanavir + emtricitabine/tenofovir df
3 Recruiting A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'
Conditions: HIV Positive;   Ageing
Intervention:
4 Not yet recruiting Comparison of 2 IUDnCT Devices
Condition: Comparing Safety With Regard to HIV Disease Progression and Acceptability of Levonorgestrel IUD to the Copper IUD Among HIV-infected ART-naïve Women.
Intervention: Device: Mirena levonorgestrel IUD and copper T-380a IUD
5 Not yet recruiting A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
Condition: HCV and HIV Seropositive Coinfection
Interventions: Drug: boceprevir;   Drug: Ribavirin;   Drug: Peginterferon alfa-2a;   Drug: Peginterferon alfa-2b
6 Recruiting Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women
Condition: Cervical Dysplasia in HIV Positive Women
Interventions: Procedure: Cryotherapy;   Procedure: LEEP
7 Recruiting Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
8 Not yet recruiting First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Intervention: Drug: Maraviroc
9 Active, not recruiting Comparison of HIV Testing Algorithms
Condition: HIV Infection
Intervention: Other: application of a confirmation test
10 Active, not recruiting Re-boosting of HIV-1 Infected Subjects With Vacc-4x
Condition: HIV-1 Infection
Intervention: Biological: Vacc-4x
11 Not yet recruiting CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
Condition: Human Immunodeficiency Virus
Interventions: Device: Intervention Arm (computer-based CARE+ Corrections tool);   Other: Educational video on opiate overdose prevention
12 Not yet recruiting A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
Condition: Human Immunodeficiency Virus-Type 1
Intervention: Drug: No intervention
13 Not yet recruiting A Study to Compare Efficacy in Terms of Plasma Human Immunodeficiency Virus-Type 1 (HIV-1) Ribonucleic Acid (RNA) Between 2 Fixed Dose Combinations After a Switch in Fully Suppressed Patients
Condition: Human Immunodeficiency Virus-type 1 Infection
Interventions: Drug: Rilpivirine;   Drug: Efavirenz;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine
14 Recruiting A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen
Condition: HIV-1 Infection
Interventions: Drug: FZD;   Drug: 3TC;   Drug: EFV;   Drug: AZT
15 Recruiting A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With HIV-1
Condition: HIV Infection
Interventions: Drug: Raltegravir Film-coated Tablet;   Drug: Raltegravir Chewable Tablet
16 Recruiting Network Supported Engagement In HIV Care
Conditions: HIV;   Patient Acceptance of Health Care
Intervention: Other: Supportive Care
17 Not yet recruiting Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
Conditions: Cocaine-Related Disorders;   HIV;   Heroin Dependence
Interventions: Drug: Methadone;   Drug: Buprenorphine;   Behavioral: Employment-based drug abstinence reinforcement
18 Recruiting Antimalarial Pharmacology in Children and Pregnant Women in Uganda
Conditions: Malaria;   HIV
Intervention:
19 Recruiting A Pilot Trial of an Individualized Web-Based Condom Use Intervention
Condition: HIV
Intervention: Behavioral: Condom-HIM
20 Recruiting Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women
Condition: HIV
Intervention: Drug: maraviroc
To Top

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
† Indicates status has not been verified in more than two years